A 20-hospital, 3-year ICMR study of over 150,000 patients finds that carbapenem drug-resistant infections are driving up both deaths and treatment costs
A large multi-centre study of over 150,000 patients in India's 20 tertiary-care hospitals has put a stark number on one of the top ten global health threats today: Antimicrobial Resistance (AMR). AMR happens when infections easier to treat earlier become difficult (or impossible) to treat due to disease-causing microbe (such as bacteria, virus, fungi, parasite) becoming drug resistant.
